Profile
Daniel W.
Docherty worked as an Executive Director of Professional Education at Shire Plc from 2000 to 2004.
He then worked as a Vice President of Marketing at Xanodyne Pharmaceuticals, Inc. from 2004 to 2009.
After that, he worked as a Senior Vice President at The Garretson Resolution Group, Inc. Mr. Docherty holds a Master's in Business Administration from Xavier University and an undergraduate degree from Miami University.
Former positions of Daniel W. Docherty
Companies | Position | End |
---|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Corporate Officer/Principal | 01/08/2004 |
The Garretson Resolution Group, Inc.
The Garretson Resolution Group, Inc. Medical/Nursing ServicesHealth Services Garretson Resolution Group, Inc. evaluates and resolves medicare reimbursement claims. Its resolution and compliance program includes: Healthcare Lien Resolution; Medicare Set-Aside; Medicare Secondary Payer Consulting and Mandatory Insurer Reporting; and Complex Settlement Administration. Garretson Resolution Group specialized administrative offerings utilize proven technology and processes to serve all settling parties interests including defendant, carrier, plaintiff counsel, claimant, court and healthcare agencies. The company was founded by Matthew L. Garretson and Jason A. Wolf in 1998 and is headquartered in Cincinnati, OH. | Corporate Officer/Principal | - |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | Sales & Marketing | - |
Training of Daniel W. Docherty
Xavier University | Masters Business Admin |
Miami University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | Health Technology |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
The Garretson Resolution Group, Inc.
The Garretson Resolution Group, Inc. Medical/Nursing ServicesHealth Services Garretson Resolution Group, Inc. evaluates and resolves medicare reimbursement claims. Its resolution and compliance program includes: Healthcare Lien Resolution; Medicare Set-Aside; Medicare Secondary Payer Consulting and Mandatory Insurer Reporting; and Complex Settlement Administration. Garretson Resolution Group specialized administrative offerings utilize proven technology and processes to serve all settling parties interests including defendant, carrier, plaintiff counsel, claimant, court and healthcare agencies. The company was founded by Matthew L. Garretson and Jason A. Wolf in 1998 and is headquartered in Cincinnati, OH. | Health Services |
- Stock Market
- Insiders
- Daniel W. Docherty